Enzo Biochem (ENZ) Stock Statistics & Valuation Metrics

Enzo Biochem has a market cap or net worth of $16.77M. The enterprise value is $2.09M.

Enzo Biochem has 52,402,805 shares outstanding. The number of shares has decreased by -2.65% in one year.

Enzo Biochem’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -42.14%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Enzo Biochem had revenue of 31.91M and earned -26.08M in profits. Earnings per share was -0.51.

In the last 12 months, operating cash flow was -15.32M and capital expenditures -1.03M, giving a free cash flow of -16.35M billion.

Enzo Biochem pays an annual dividend of $0.1, resulting in a dividend yield of ―

Enzo Biochem upcoming earnings date is ―, ―.

Enzo Biochem as a current ratio of 2.82, with Debt / Equity ratio of 6.92%

In the past 12 months, Enzo Biochem has paid 16.26M in taxes.

Enzo Biochem EV to EBITDA ratio is -1.10, with an EV/FCF ratio of -0.34.

Enzo Biochem has $36.69M in cash and marketable securities with $3.00M in debt, giving a net cash position of -$33.69M billion.

Gross margin is 43.75%, with operating margin of -30.77%, and net profit margin of -81.73%.

The average price target for Enzo Biochem is ―, which is 11.43% higher than the current price. The consensus rating is ―